Arham Technologies Board Approves Migration of Equity Listing from SME Platform to NSE Main Board

Arham Technologies Board Approves Migration of Equity Listing from SME Platform to NSE Main Board

Arham Technologies Board Approves Migration of Equity Listing from SME Platform to NSE Main Board​

Arham Technologies Limited, a listed entity, announced that its Board of Directors approved the migration and trading of the company's equity shares from the Small and Medium Enterprise (SME) Platform (EMERGE) of the National Stock Exchange of India (NSE) to the Main Board of the NSE. The decision was ratified during a meeting held on June 16, 2026.

The move signifies Arham Technologies’ progression toward trading on a major stock exchange platform. The Board meeting commenced at 1:00 P.M. and concluded an hour later.

While the approval marks a significant corporate development, the decision remains contingent upon various external approvals. The company noted that the migration is subject to the requisite approval of its members (shareholders), the Stock Exchanges, and any other necessary regulatory authorities.

As part of the process, notice for a Postal Ballot will be sent to the members shortly, allowing stakeholders to participate in the proposed change in listing status.

ARHAM Stock Price Movement​

Shares of Arham Technologies Limited are surging to ₹150.00 as of 1:59 PM today, representing a robust intraday climb of 9.77%. The stock is supported by strong market action, with 100,000 shares trading during the live session.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top